Hui Jun Deng

Director of Finance/CFO at IMPACT THERAPEUTICS, INC

51 year

Consumer Services

Commercial Services

Health Technology

Profile

Hui Jun Deng is currently Executive Director-Finance at IMPACT Therapeutics, Inc. since 2024.
Ms. Deng is also a member of The Chartered Institute of Management Accountants and a member of The American Institute of Certified Public Accountants.
Ms. Deng completed an undergraduate degree at Central South University in 1997.

Hui Jun Deng active positions

Companies	Position	Start
IMPACT THERAPEUTICS, INC	Director of Finance/CFO	30/04/2024
The Chartered Institute of Management Accountants The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University	Corporate Officer/Principal	-
The American Institute of Certified Public Accountants The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants	Corporate Officer/Principal	-

All active positions of Hui Jun Deng

Training of Hui Jun Deng

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Hui Jun Deng's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	4
The Chartered Institute of Management Accountants The Chartered Institute of Management Accountants Other Consumer ServicesConsumer Services College/University	Consumer Services
The American Institute of Certified Public Accountants The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Association of accountants	Commercial Services
Central South University Central South University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
IMPACT Therapeutics, Inc. IMPACT Therapeutics, Inc. BiotechnologyHealth Technology Operates as a commercial-stage biotechnology company that develops anti-cancer therapies and pharmaceutical products	Health Technology